News - Aenitis

Press releases

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes

Access the full Press Release: English Version / French Version ● Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies● Transformative alternative for sorting rare and complex cells: Acoustic microspheres

Upcoming events

Aenitis will be participating in the JP Morgan 43rd Annual Healthcare Conference, January 13-16

Emmanuel Vincent, our CEO, will be attending the JP Morgan 43rd Annual Healthcare Conference in San Francisco, CA, USA, from 13 to 16 January. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for

Media coverage

Aenitis has been featured in Biotech et Finances

We are pleased to share that Aenitis has been featured in Biotech et Finances! Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology. During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our

Media coverage

Aenitis has been featured in Les Echos

We are delighted to announce that Aenitis has been featured in Les Echos following our successful fundraising to redefine bioproduction with our sole-in-class acoustofluidic technology!Thanks to Paul Molga for this enriching interview. Headline: « Aenitis raises 6.5 million euros for its cell sorting machines by levitation »Read the full article on Les

Press releases

Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology (2024)

Access the full Press Release: English Version / French Version ● Aenitis is set to transform the bioproduction industry by addressing theincreasing need for scalable, cost-effective, and highly precise cell processingtechnologies.● Mitis™, the flagship product of its unique Acoustofluidic Technology, is alreadyused across various applications, from research to clinical and

Past events

Aenitis will be participating in the Matinale Deeptech on November, 7th

Emmanuel Vincent, our CEO, will participate in the POC Media – Matinale Deeptech: “Les Nouveaux Acteurs des Biothérapies,” organized by the Agence de l’Innovation en Santé and Polepharma at the Paris Santé Cancer Campus on November 7th. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive,